Arcus Biosciences, Inc. (RCUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1243752,
    "name": "Arcus Biosciences, Inc.",
    "stock_name": "Arcus Biosciences, Inc.",
    "full_name": "Arcus Biosciences, Inc.",
    "name_url": "stocks-analysis/arcus-biosciences-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "25.26",
    "chg": -0.37,
    "chgp": "-1.44%",
    "dir": -1,
    "prev_price": "25.63",
    "mcapval": "1,217.57",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US03969F1093",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.77 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arcus-biosciences-inc-1243752-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arcus Biosciences Hits Day High with Strong 8.19% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-hits-day-high-with-strong-819-intraday-surge-3626739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcusBioscience_priceRelatedfactors_3626739.png",
        "date": "2025-10-16 19:04:57",
        "description": "Arcus Biosciences, Inc. has seen a significant increase in its stock price today, contrasting with a slight decline in the S&P 500. While the company has shown strong weekly and monthly gains, it faces longer-term challenges, including profitability concerns and a declining performance over the past year and three years."
      },
      {
        "title": "Arcus Biosciences Hits Day High with 13.97% Surge Amid Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-hits-day-high-with-1397-surge-amid-market-decline-3620264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcusBioscience_priceRelatedfactors_3620264.png",
        "date": "2025-10-14 19:36:20",
        "description": "Arcus Biosciences, Inc. saw a notable increase in its stock price on October 13, 2025, reaching an intraday high. The company has outperformed the S&P 500 recently, despite facing challenges such as low return on equity and negative EBITDA. Its market capitalization is classified as small-cap."
      },
      {
        "title": "Arcus Biosciences Opens with 8.22% Gain, Contrasting S&P 500's Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-opens-with-822-gain-contrasting-sp-500s-decline-3712374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArcusBioscience_gapup_3712374.png",
        "date": "2025-10-14 19:15:30",
        "description": "Arcus Biosciences, Inc. opened with a significant gain amid a broader market decline. Over the past month, the company has shown strong performance, despite facing challenges such as low profitability and a substantial drop in profits. Technical indicators present a mixed outlook for the stock's future."
      },
      {
        "title": "Arcus Biosciences Hits Day High with Strong 7.27% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-hits-day-high-with-strong-727-intraday-surge-3608144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcusBioscience_priceRelatedfactors_3608144.png",
        "date": "2025-10-09 21:02:07",
        "description": "Arcus Biosciences, Inc. has seen a significant intraday increase, contrasting with a slight decline in the S&P 500. Despite recent gains, the company faces long-term challenges, including a decline in one- and three-year performance metrics, low return on equity, and negative EBITDA, indicating ongoing financial struggles."
      },
      {
        "title": "Arcus Biosciences Hits Day High with Strong 8.46% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-hits-day-high-with-strong-846-intraday-surge-3601764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcusBioscience_priceRelatedfactors_3601764.png",
        "date": "2025-10-07 22:29:09",
        "description": "Arcus Biosciences, Inc. has seen significant short-term gains, with an 8.46% increase today and an 8.71% rise over the past week. However, the company faces long-term challenges, including a year-to-date decline and a notable drop over three years, alongside low profitability and a negative debt-to-equity ratio."
      },
      {
        "title": "Arcus Biosciences Hits Day High with 9.94% Surge in Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-hits-day-high-with-994-surge-in-strong-intraday-performance-3585917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcusBioscience_priceRelatedfactors_3585917.png",
        "date": "2025-10-01 16:20:15",
        "description": "Arcus Biosciences, Inc. saw a notable increase in stock performance on September 30, 2025, reaching an intraday high of USD 13.62. Despite recent gains, the company has faced profitability challenges, with a low return on equity and a negative EBITDA, and a market capitalization of USD 1,218 million."
      },
      {
        "title": "Arcus Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-inc-technical-trend-shifts-from-sideways-to-bullish-amid-stock-price-increase-3586517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ArcusBioscience_technicaldot_3586517.png",
        "date": "2025-09-30 16:18:14",
        "description": "Arcus Biosciences, Inc. has recently revised its evaluation amid market dynamics, with its stock price showing a slight increase. The company has experienced notable volatility over the past year, with significant fluctuations in stock performance compared to the S&P 500, reflecting both short-term gains and longer-term challenges."
      },
      {
        "title": "Is Arcus Biosciences, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-arcus-biosciences-inc-technically-bullish-or-bearish-3582524",
        "imagepath": "",
        "date": "2025-09-30 11:18:45",
        "description": "As of 26 September 2025, the technical trend for Arcus Biosciences, Inc. has changed from sideways to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and the Bollinger Bands show a mildly bearish signal on that same timeframe. The KST is bullish weekly but bearish monthly, while the Dow Theory and OBV both indicate a mildly bullish trend on both weekly and monthly periods.\n\nIn terms of performance, Arcus has outperformed the S&P 500 over the past week and month, with returns of 3.63% and 23.70% respectively, compared to the S&P 500's -0.31% and 2.75%. However, the longer-term returns are significantly negative, with a year-to-date return of -13.77% versus the S&P 500's 12.96%, and a 3-year return of -47.63% compared to 81.77% for the index.\n\nOverall, the current technical stance is bullish, but the strength ..."
      },
      {
        "title": "Arcus Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arcus-biosciences-forms-golden-cross-signaling-potential-bullish-breakout-3579703",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ArcusBioscience_goldencross_3579703.png",
        "date": "2025-09-29 15:46:37",
        "description": "Arcus Biosciences, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Technical indicators show a mixed but generally positive outlook, with bullish trends in moving averages and MACD. Despite a challenging year, the stock has shown resilience with notable recent gains and a strong one-month performance."
      }
    ],
    "total": 18,
    "sid": "1243752",
    "stock_news_url": "https://www.marketsmojo.com/news/arcus-biosciences-inc-1243752"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Arcus Biosciences Hits Day High with Strong 8.19% Intraday Surge

2025-10-16 19:04:57

Arcus Biosciences, Inc. has seen a significant increase in its stock price today, contrasting with a slight decline in the S&P 500. While the company has shown strong weekly and monthly gains, it faces longer-term challenges, including profitability concerns and a declining performance over the past year and three years.

Arcus Biosciences Hits Day High with 13.97% Surge Amid Market Decline

2025-10-14 19:36:20

Arcus Biosciences, Inc. saw a notable increase in its stock price on October 13, 2025, reaching an intraday high. The company has outperformed the S&P 500 recently, despite facing challenges such as low return on equity and negative EBITDA. Its market capitalization is classified as small-cap.

Arcus Biosciences Opens with 8.22% Gain, Contrasting S&P 500's Decline

2025-10-14 19:15:30

Arcus Biosciences, Inc. opened with a significant gain amid a broader market decline. Over the past month, the company has shown strong performance, despite facing challenges such as low profitability and a substantial drop in profits. Technical indicators present a mixed outlook for the stock's future.

Arcus Biosciences Hits Day High with Strong 7.27% Intraday Surge

2025-10-09 21:02:07

Arcus Biosciences, Inc. has seen a significant intraday increase, contrasting with a slight decline in the S&P 500. Despite recent gains, the company faces long-term challenges, including a decline in one- and three-year performance metrics, low return on equity, and negative EBITDA, indicating ongoing financial struggles.

Arcus Biosciences Hits Day High with Strong 8.46% Intraday Surge

2025-10-07 22:29:09

Arcus Biosciences, Inc. has seen significant short-term gains, with an 8.46% increase today and an 8.71% rise over the past week. However, the company faces long-term challenges, including a year-to-date decline and a notable drop over three years, alongside low profitability and a negative debt-to-equity ratio.

Arcus Biosciences Hits Day High with 9.94% Surge in Strong Intraday Performance

2025-10-01 16:20:15

Arcus Biosciences, Inc. saw a notable increase in stock performance on September 30, 2025, reaching an intraday high of USD 13.62. Despite recent gains, the company has faced profitability challenges, with a low return on equity and a negative EBITDA, and a market capitalization of USD 1,218 million.

Arcus Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators

2025-09-30 16:18:14

Arcus Biosciences, Inc. has recently revised its evaluation amid market dynamics, with its stock price showing a slight increase. The company has experienced notable volatility over the past year, with significant fluctuations in stock performance compared to the S&P 500, reflecting both short-term gains and longer-term challenges.

Is Arcus Biosciences, Inc. technically bullish or bearish?

2025-09-30 11:18:45

As of 26 September 2025, the technical trend for Arcus Biosciences, Inc. has changed from sideways to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and the Bollinger Bands show a mildly bearish signal on that same timeframe. The KST is bullish weekly but bearish monthly, while the Dow Theory and OBV both indicate a mildly bullish trend on both weekly and monthly periods. In terms of performance, Arcus has outperformed the S&P 500 over the past week and month, with returns of 3.63% and 23.70% respectively, compared to the S&P 500's -0.31% and 2.75%. However, the longer-term returns are significantly negative, with a year-to-date return of -13.77% versus the S&P 500's 12.96%, and a 3-year return of -47.63% compared to 81.77% for the index. Overall, the current technical stance is bullish, but the strength ...

Arcus Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout

2025-09-29 15:46:37

Arcus Biosciences, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Technical indicators show a mixed but generally positive outlook, with bullish trends in moving averages and MACD. Despite a challenging year, the stock has shown resilience with notable recent gains and a strong one-month performance.

View All News